Zeibecoglou K, Ying S, Yamada T, North J, Burman J, Bungre J, Meng Q, Kay A B, Robinson D S
Department of Allergy and Clinical Immunology, Imperial College School of Medicine at the National Heart and Lung Institute, London, United Kingdom.
J Allergy Clin Immunol. 1999 Jan;103(1 Pt 1):99-106. doi: 10.1016/s0091-6749(99)70532-4.
Eosinophil infiltration of the bronchial mucosa is characteristic of asthma. Eosinophils differentiate from CD34(+) progenitors. Animal models suggest cooperation between IL-5 and eotaxin to allow rapid mobilization of a pool of bone marrow eosinophils followed by recruitment to the airway mucosa.
The purpose of this study was to enumerate CD34(+) cell numbers in blood and bone marrow from atopic asthmatics and control subjects and to test the hypothesis that there is an increased bone marrow pool of CCR3(+) eosinophils in patients with atopic asthma, as compared with control subjects.
Bone marrow aspirates and peripheral blood were obtained from volunteers with asthma and control volunteers. CD34(+) cell numbers were evaluated by flow cytometry, and eosinophil colony-forming activity was evaluated by methylcellulose cultures. Mature eosinophils, eosinophil myelocytes, metamyelocytes, and band forms (immature eosinophils) were enumerated by morphologic findings and immunocytochemistry for eosinophil cationic protein. CCR3 and eotaxin mRNA expression was examined by in situ hybridization, and protein expression was examined by immunocytochemistry. CCR3(+) cells were further identified with Chromotrope 2R staining.
CD34(+) cell numbers in bone marrow were increased in atopic subjects. Numbers of eosinophil colony-forming units in blood and bone marrow did not differ between groups. Percentages of both mature and immature eosinophils were increased in bone marrow from patients with atopic asthma, but not atopic patients with no asthma or normal control subjects. CCR3 was expressed by immature and mature bone marrow eosinophils. Eotaxin was expressed by bone marrow cells from all 3 groups, but there was no increase in subjects with asthma.
These findings suggest that in humans there is an increased bone marrow pool of CCR3(+) mature and immature eosinophils available for rapid mobilization in subjects with asthma but not in atopic subjects with no asthma.
支气管黏膜嗜酸性粒细胞浸润是哮喘的特征。嗜酸性粒细胞由CD34(+)祖细胞分化而来。动物模型提示,白细胞介素-5(IL-5)和嗜酸性粒细胞趋化因子协同作用,使骨髓中一群嗜酸性粒细胞快速动员,随后募集至气道黏膜。
本研究旨在计数特应性哮喘患者和对照者血液及骨髓中CD34(+)细胞数量,并检验特应性哮喘患者骨髓中CCR3(+)嗜酸性粒细胞池比对照者增加的假说。
从哮喘志愿者和对照志愿者获取骨髓抽吸物和外周血。通过流式细胞术评估CD34(+)细胞数量,通过甲基纤维素培养评估嗜酸性粒细胞集落形成活性。通过形态学检查和嗜酸性粒细胞阳离子蛋白免疫细胞化学计数成熟嗜酸性粒细胞、嗜酸性粒细胞中幼粒细胞、晚幼粒细胞和杆状核细胞(未成熟嗜酸性粒细胞)。通过原位杂交检测CCR3和嗜酸性粒细胞趋化因子mRNA表达,通过免疫细胞化学检测蛋白表达。用铬变素2R染色进一步鉴定CCR3(+)细胞。
特应性受试者骨髓中CD34(+)细胞数量增加。两组间血液和骨髓中嗜酸性粒细胞集落形成单位数量无差异。特应性哮喘患者骨髓中成熟和未成熟嗜酸性粒细胞百分比均增加,但无哮喘的特应性患者或正常对照者未增加。CCR3由未成熟和成熟骨髓嗜酸性粒细胞表达。嗜酸性粒细胞趋化因子由所有3组的骨髓细胞表达,但哮喘患者无增加。
这些发现提示,在人类,哮喘患者骨髓中CCR3(+)成熟和未成熟嗜酸性粒细胞池增加,可用于快速动员,而无哮喘的特应性受试者则不然。